Paragon 28 (P28) announced the acquisition of Disior, a three-dimensional analytics pre-operative planning software company based in Helsinki, Finland, focused on foot and ankle anatomy. The transaction was completed for $18 million in cash with $8 million in potential technology and commercial milestones.
Disior will be an integral component to SMART 28™, Paragon 28’s ecosystem of enabling technologies for pre-operative planning, intra-operative support and post-operative evaluation.
Disior’s anatomy-specific surgical modules, which are FDA-cleared and CE-Marked, will provide foot and ankle surgeons the objective data needed for the diagnosis and creation of patient-specific surgical plans, and assessment of patient outcomes. Disior is also complementary to the assets of Additive Orthopaedics, which P28 acquired in 2021.
“Disior advances our previously communicated growth strategy to target unique technologies and will immediately accelerate our internal research and development efforts, plus provide surgeons unique pre-operative planning capabilities. Disior’s software combined with our broad product portfolio further differentiates us from the competition,” said Albert DaCosta, Chairman and CEO of P28. “P28’s ultimate mission is to improve patient outcomes, and we believe our SMART 28 ecosystem will modernize all aspects of foot and ankle surgery.”
Paragon 28 (P28) announced the acquisition of Disior, a three-dimensional analytics pre-operative planning software company based in Helsinki, Finland, focused on foot and ankle anatomy. The transaction was completed for $18 million in cash with $8 million in potential technology and commercial milestones.
Disior will be an integral component to...
Paragon 28 (P28) announced the acquisition of Disior, a three-dimensional analytics pre-operative planning software company based in Helsinki, Finland, focused on foot and ankle anatomy. The transaction was completed for $18 million in cash with $8 million in potential technology and commercial milestones.
Disior will be an integral component to SMART 28™, Paragon 28’s ecosystem of enabling technologies for pre-operative planning, intra-operative support and post-operative evaluation.
Disior’s anatomy-specific surgical modules, which are FDA-cleared and CE-Marked, will provide foot and ankle surgeons the objective data needed for the diagnosis and creation of patient-specific surgical plans, and assessment of patient outcomes. Disior is also complementary to the assets of Additive Orthopaedics, which P28 acquired in 2021.
“Disior advances our previously communicated growth strategy to target unique technologies and will immediately accelerate our internal research and development efforts, plus provide surgeons unique pre-operative planning capabilities. Disior’s software combined with our broad product portfolio further differentiates us from the competition,” said Albert DaCosta, Chairman and CEO of P28. “P28’s ultimate mission is to improve patient outcomes, and we believe our SMART 28 ecosystem will modernize all aspects of foot and ankle surgery.”
Copy to clipboard 
